Genscript Biotech Statistics

Total Valuation

HKG:1548 has a market cap or net worth of HKD 26.78 billion. The enterprise value is 27.59 billion.

Market Cap	26.78B
Enterprise Value	27.59B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:1548 has 2.18 billion shares outstanding. The number of shares has increased by 3.37% in one year.

Current Share Class	2.17B
Shares Outstanding	2.18B
Shares Change (YoY)	+3.37%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	14.62%
Float	1.37B

Valuation Ratios

The trailing PE ratio is 1.16 and the forward PE ratio is 19.35.

PE Ratio	1.16
Forward PE	19.35
PS Ratio	5.80
PB Ratio	0.80
P/TBV Ratio	0.80
P/FCF Ratio	n/a
P/OCF Ratio	45.57
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 77.35, with an EV/FCF ratio of -29.57.

EV / Earnings	1.20
EV / Sales	5.98
EV / EBITDA	77.35
EV / EBIT	n/a
EV / FCF	-29.57

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.17.

Current Ratio	2.72
Quick Ratio	2.46
Debt / Equity	0.17
Debt / EBITDA	8.51
Debt / FCF	-6.02
Interest Coverage	1.16

Financial Efficiency

Return on equity (ROE) is -5.46% and return on invested capital (ROIC) is 0.15%.

Return on Equity (ROE)	-5.46%
Return on Assets (ROA)	0.13%
Return on Invested Capital (ROIC)	0.15%
Return on Capital Employed (ROCE)	0.19%
Revenue Per Employee	829,323
Profits Per Employee	4.13M
Employee Count	5,568
Asset Turnover	0.14
Inventory Turnover	7.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.47% in the last 52 weeks. The beta is 0.97, so HKG:1548's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	+9.47%
50-Day Moving Average	11.40
200-Day Moving Average	11.47
Relative Strength Index (RSI)	68.03
Average Volume (20 Days)	16,550,143

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1548 had revenue of HKD 4.62 billion and earned 23.01 billion in profits. Earnings per share was 10.85.

Revenue	4.62B
Gross Profit	2.11B
Operating Income	72.10M
Pretax Income	-1.33B
Net Income	23.01B
EBITDA	544.00M
EBIT	72.10M
Earnings Per Share (EPS)	10.85

Full Income Statement

Balance Sheet

The company has 4.83 billion in cash and 5.62 billion in debt, giving a net cash position of -796.15 million or -0.37 per share.

Cash & Cash Equivalents	4.83B
Total Debt	5.62B
Net Cash	-796.15M
Net Cash Per Share	-0.37
Equity (Book Value)	33.58B
Book Value Per Share	15.66
Working Capital	4.10B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 587.59 million and capital expenditures -1.52 billion, giving a free cash flow of -933.18 million.

Operating Cash Flow	587.59M
Capital Expenditures	-1.52B
Free Cash Flow	-933.18M
FCF Per Share	-0.43

Full Cash Flow Statement

Margins

Gross margin is 45.77%, with operating and profit margins of 1.56% and 498.22%.

Gross Margin	45.77%
Operating Margin	1.56%
Pretax Margin	-28.73%
Profit Margin	498.22%
EBITDA Margin	11.78%
EBIT Margin	1.56%
FCF Margin	n/a

Dividends & Yields

HKG:1548 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.37%
Shareholder Yield	n/a
Earnings Yield	85.91%
FCF Yield	-3.48%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1548 has an Altman Z-Score of 2.99. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.99
Piotroski F-Score	n/a